Health Care & Life Sciences » Pharmaceuticals | DelMar Pharmaceuticals Inc.

DelMar Pharmaceuticals Inc.

DelMar Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.31
Market Cap
$4 M
Shares Outstanding
3.83 M
Public Float
23.61 M

Profile

Address
999 West Broadway
Vancouver British Columbia V5Z 1K5
Canada
Employees -
Website http://www.delmarpharma.com
Updated 07/08/2019
DelMar Pharmaceuticals, Inc. is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. It offers VAL-083; drug discovery research; as well as patents and intellectual property. The company was founded by Jeffrey A.

Financials

View All

Robert E. Hoffman
Chairman
Dennis M. Brown
Director & Chief Scientific Officer